Extracranial-intracranial bypass for symptomatic intracranial arterial occlusion: a meta-analysis of individual
Jin Hean Koh1, Claire Yi Jia Lim2, Lucas Tze Peng Tan2
1Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Insights
Adding extracranial-intracranial (EC-IC) bypass surgery to medical therapy does not significantly reduce the risk of stroke or death in patients with symptomatic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusions. This finding is based on a meta-analysis of recent randomized trials.
Area of Science:
- Neurology
- Neurosurgery
- Cardiovascular Medicine
Background:
- Patients with symptomatic atherosclerotic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusions have a high risk of recurrent ischemic stroke.
- Previous trials suggested no benefit from extracranial-intracranial (EC-IC) bypass surgery, potentially due to underpowering.
Purpose of the Study:
- To evaluate the efficacy of EC-IC bypass surgery in reducing the risk of stroke or death in patients with symptomatic ICA or MCA occlusions.
- To analyze data from randomized trials comparing EC-IC bypass plus medical therapy versus medical therapy alone.
Main Methods:
- Systematic review of randomized trials from PubMed, Embase, and Cochrane Library.
- Meta-analysis using reconstructed individual patient data (one-stage and two-stage) to calculate hazard ratios (HRs).
- Primary outcome: composite of stroke or death within 30 days, or ipsilateral ischemic stroke beyond 30 days up to 2 years.
Main Results:
- Four trials with 2102 participants were included in the meta-analysis.
- No statistically significant difference in the primary composite outcome was found between the EC-IC bypass group and the medical therapy alone group (one-stage HR 1.019, P=0.06; two-stage HR 0.954, P=0.21).
- Rates of ipsilateral ischemic stroke, any stroke or death, and any stroke were similar between groups at 2 years.
Conclusions:
- Adding EC-IC bypass surgery to medical therapy does not significantly lower the risk of the composite outcome of stroke or death in patients with symptomatic ICA or MCA occlusions.
- The findings suggest that current medical therapy alone is as effective as adding bypass surgery for stroke prevention in this patient population.
Abstract:
Patients with symptomatic atherosclerotic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusions face a high risk of recurrent ischaemic stroke despite best medical therapy. Previous trials of extracranial-intracranial (EC-IC) bypass surgery showed no benefit for stroke prevention in this population, but they may have been underpowered. This study evaluates the efficacy of EC-IC bypass surgery in reducing the risk of the composite outcome of stroke or death within 30 days or ipsilateral ischaemic stroke beyond 30 days through 2 years. Following a PROSPERO-registered protocol (CRD42023457824), we conducted a systematic review of PubMed, Embase and Cochrane Library for randomised trials, comparing the use of EC-IC bypass surgery plus medical therapy versus medical therapy alone. The primary outcome was a composite of stroke or death within 30 days or ipsilateral ischaemic stroke beyond 30 days through 2 years after randomisation. One-stage and two-stage meta-analyses using reconstructed individual patient data in hazard ratios (HRs) were performed. Four trials (2102 participants) were included. No statistically significant differences were observed between the two groups in the one-stage (HR 1.019, 95% confidence interval [CI] 0.860-1.209, P = 0.06) and two-stage (HR 0.954, 95% CI 0.841-1.241, P = 0.21) meta-analyses. Rates of ipsilateral ischaemic stroke, any stroke or death, and any stroke were also similar between groups at 2 years. In symptomatic ICA or MCA occlusion, adding bypass surgery to medical therapy does not significantly lower the risk of the composite outcome of stroke or death compared to medical therapy alone.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology


